Publications en collaboration avec des chercheurs de Cambridge Biomedical Research Centre (1)

2012

  1. Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 30, Núm. 25, pp. 3084-3092